SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-22-000689
Filing Date
2022-01-07
Accepted
2022-01-07 16:40:07
Documents
2
Period of Report
2022-01-07

Document Format Files

Seq Description Document Type Size
1 6-K NASDAQ COMPLIANCE mito-6k_20220131.htm 6-K 23036
2 EX-99.1 mito-ex991_6.htm EX-99.1 12691
  Complete submission text file 0001564590-22-000689.txt   36760
Mailing Address 190 ELGIN AVENUE GEORGE TOWN GRAND CAYMAN E9 KY1-9005
Business Address 190 ELGIN AVENUE GEORGE TOWN GRAND CAYMAN E9 KY1-9005 617-600-6888
Stealth BioTherapeutics Corp (Filer) CIK: 0001696396 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38810 | Film No.: 22518611
SIC: 2834 Pharmaceutical Preparations